Summa Equity Acquires Majority Stake in myneva
June 30, 2021
Summa Equity Fund II has acquired a majority stake in myneva, a Hamburg‑based European software provider offering SaaS solutions for the social care sector. myneva serves around 2,000 customers across six European countries, has approximately 220 employees and €30m in revenue; Summa intends to support further digitization, international expansion and continued growth.
- Buyers
- Summa Equity Fund II, Summa Equity
- Targets
- myneva
- Industry
- Software
- Location
- Hamburg, Germany
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
myneva Group Acquires DM EDV GmbH from ARZ Haan AG
January 2, 2025
Software
The Summa Equity–owned myneva Group has acquired DM EDV GmbH from ARZ Haan AG. The Germany-based software provider (about 65 employees and 1,500+ customers) will have its DM7 solution integrated into the myneva Care Platform by 2025, expanding myneva's product portfolio and customer base in the social care sector.
-
myneva Group (Summa Equity) Acquires Kuidado GmbH (CareMates)
July 18, 2025
Software
myneva Group, a Summa Equity portfolio company, has acquired Kuidado GmbH, the developer of the AI-powered CareMates CRM for patient admissions. The CareMates team and its four founders will join myneva; the product will remain available standalone and will be integrated into myneva's care platform to accelerate onboarding and reduce intake time by up to 80%.
-
Summa Equity Acquires Majority Stake in Axion BioSystems
July 15, 2021
Medical Devices
Summa Equity Fund II has acquired a majority stake in Axion BioSystems, a US life science tools company that develops MEA (microelectrode array) and impedance-based bioelectronic assay technologies. Summa plans to support Axion's commercial scale-up and global growth to accelerate adoption of its platforms across academia and biopharma, particularly in cell and gene therapy and drug discovery applications.
-
Summa Equity Acquires Majority Stake in Sengenics
October 14, 2020
Biotechnology
Summa Equity Fund II has acquired a majority stake in Sengenics, a functional proteomics company that commercialises the KREX technology for full‑length, correctly folded protein production and autoantibody detection. The investment will support Sengenics' product development, global expansion and accelerated commercial adoption across pharma, academic research and diagnostics.
-
Summa Equity Acquires Majority Stake in Logpoint
March 2, 2023
Cybersecurity
Summa Equity is acquiring a majority stake in Logpoint, the Copenhagen-based cybersecurity vendor, via its EUR 2.3bn Fund III to build a European cybersecurity powerhouse. The transaction leaves Yttrium as a significant minority shareholder and is subject to final regulatory approval (expected Q2 2023).
-
Summa Equity and Goldman Sachs Acquire Stakes in EcoOnline
February 18, 2020
Cloud & SaaS
Summa Equity Fund II and Goldman Sachs Merchant Banking Division have each agreed to acquire a 33% ownership stake in EcoOnline from selling shareholders including Summa Equity Fund I and Viking Venture, securing new capital to support the company's international expansion. The transaction, which keeps Summa Equity as a controlling shareholder, will fund organic and acquisition-based growth of EcoOnline's HSEQ SaaS platform and is subject to antitrust approval.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.